Go Pro
→ 3 Ways AI Can Reshape Your Retirement For The Worse (From American Hartford Gold) (Ad)tc pixel Free NYT Stock Alerts

New York Times (NYT) Financials

New York Times logo
$64.40 +0.86 (+1.35%)
As of 01:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for New York Times

Annual Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 63 29 4.30 126 140 100 220 174 232 294 344
Consolidated Net Income / (Loss)		 63 24 6.84 127 140 101 220 174 233 294 344
Net Income / (Loss) Continuing Operations		 63 26 7.27 127 140 101 220 174 233 294 344
Total Pre-Tax Income 		97 31 111 176 164 115 291 236 303 383 451
Total Operating Income		 137 113 177 190 176 176 268 202 276 351 432
Total Gross Profit		 961 926 1,413 796 824 824 1,035 1,099 1,177 1,276 1,435
Total Revenue		 1,579 1,555 1,666 1,744 1,812 1,784 2,075 2,308 2,426 2,586 2,825
Operating Revenue		 1,490 1,555 1,666 1,744 1,812 1,784 2,075 2,308 2,426 2,586 2,825
Total Cost of Revenue		 618 629 253 948 988 959 1,040 1,209 1,249 1,310 1,390
Operating Cost of Revenue		 618 629 253 948 988 959 1,040 1,209 1,249 1,310 1,390
Total Operating Expenses		 825 813 1,236 606 648 648 767 897 901 925 1,004
Selling, General & Admin Expense		 714 728 815 197 207 224 250 289 311 308 328
Marketing Expense		 - - - 271 273 229 295 268 260 278 307
Research & Development Expense		 - - - 84 106 133 161 204 229 248 264
Depreciation Expense		 62 62 62 59 61 62 58 83 86 83 85
Other Operating Expenses / (Income)		 49 6.73 359 -4.85 -2.05 0.00 0.00 15 -0.61 -2.98 2.97
Impairment Charge		 - - - - - 0.00 0.00 4.07 15 0.00 2.86
Other Special Charges / (Income)		 0.00 - - - 0.00 0.00 3.83 0.00 0.00 11 13
Total Other Income / (Expense), net		 -40 -82 -65 -14 -11 -61 22 34 26 32 20
Interest & Investment Income		 -0.78 -36 19 11 0.00 5.00 0.00 41 24 36 38
Other Income / (Expense), net		 - -11 -64 -8.27 -7.30 -89 -10 -6.66 2.74 -4.16 -19
Income Tax Expense		 34 4.42 104 49 24 15 71 62 70 90 107
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.40 -5.24 2.54 1.78 0.00 0.73 0.00 0.00 0.37 0.00 0.00
Basic Earnings per Share		 $0.38 $0.18 $0.03 $0.76 $0.84 $0.60 $1.31 $1.04 $1.41 $1.79 $2.11
Weighted Average Basic Shares Outstanding		 164.39M 161.13M 161.93M 164.85M 166.04M 166.97M 167.93M 166.87M 164.72M 164.43M 163.16M
Diluted Earnings per Share		 $0.38 $0.18 $0.03 $0.75 $0.83 $0.60 $1.31 $1.04 $1.40 $1.77 $2.09
Weighted Average Diluted Shares Outstanding		 166.42M 162.82M 164.26M 166.94M 167.55M 168.04M 168.53M 167.14M 165.66M 165.80M 164.94M
Weighted Average Basic & Diluted Shares Outstanding		 166.40M 161.50M 143.20M 165.40M 166.40M 167.44M 167.53M 164.47M 164.10M 163.30M 161.24M
Cash Dividends to Common per Share		 $0.16 $0.16 $0.16 $0.16 $0.20 $0.24 $0.28 $0.36 $0.44 $0.52 $0.72

Quarterly Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 110 40 66 64 124 50 83 82 130 88 93
Consolidated Net Income / (Loss)		 110 40 66 64 124 50 83 82 130 88 93
Net Income / (Loss) Continuing Operations		 110 40 66 64 124 50 83 82 130 88 93
Total Pre-Tax Income 		140 56 87 85 156 64 112 108 168 98 125
Total Operating Income		 129 48 79 77 147 59 107 105 162 91 118
Total Gross Profit		 355 277 302 308 389 301 347 352 435 349 395
Total Revenue		 676 594 625 640 727 636 686 701 802 712 762
Operating Revenue		 676 594 625 640 727 636 686 701 802 712 762
Total Cost of Revenue		 321 317 323 332 338 335 339 349 367 363 368
Operating Cost of Revenue		 321 317 323 332 338 335 339 349 367 363 368
Total Operating Expenses		 226 229 223 232 242 243 241 247 274 259 277
Selling, General & Admin Expense		 76 79 77 76 76 80 83 77 89 86 86
Marketing Expense		 68 65 61 69 83 66 69 80 92 77 86
Research & Development Expense		 58 63 62 61 62 67 64 67 67 70 70
Depreciation Expense		 22 21 21 21 21 21 21 21 21 21 21
Other Operating Expenses / (Income)		 - 0.00 0.00 0.00 - 4.45 0.00 0.00 -1.49 0.00 9.22
Other Special Charges / (Income)		 - 0.99 1.98 4.62 3.21 4.40 3.49 2.41 3.02 4.21 4.63
Total Other Income / (Expense), net		 11 7.34 7.67 8.32 9.00 5.33 5.11 3.21 6.04 7.70 7.20
Interest & Investment Income		 - 8.39 8.70 9.37 - 9.97 9.75 7.85 11 11 11
Other Income / (Expense), net		 0.68 -1.05 -1.02 -1.05 -1.03 -4.64 -4.64 -4.64 -4.64 -3.58 -3.64
Income Tax Expense		 30 15 22 21 32 14 29 26 38 10 32
Basic Earnings per Share		 $0.66 $0.25 $0.40 $0.39 $0.75 $0.30 $0.51 $0.50 $0.80 $0.54 $0.58
Weighted Average Basic Shares Outstanding		 164.72M 164.63M 164.54M 164.42M 164.43M 163.78M 163.33M 163.02M 163.16M 162.04M 162.04M
Diluted Earnings per Share		 $0.67 $0.24 $0.40 $0.39 $0.74 $0.30 $0.50 $0.50 $0.79 $0.54 $0.57
Weighted Average Diluted Shares Outstanding		 165.66M 165.63M 165.51M 165.85M 165.80M 164.91M 164.35M 164.40M 164.94M 163.70M 163.04M
Weighted Average Basic & Diluted Shares Outstanding		 164.10M 164.31M 164.23M 163.95M 163.30M 163.05M 162.82M 162.35M 161.24M 161.86M 161.28M
Cash Dividends to Common per Share		 $0.11 $0.13 $0.13 $0.13 $0.13 $0.18 $0.18 $0.18 $0.18 $0.23 $0.23

Annual Cash Flow Statements for New York Times

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -70 -8.68 75 60 -12 54 33 -97 68 -88 57
Net Cash From Operating Activities		 179 104 87 157 190 298 269 151 361 411 584
Net Cash From Continuing Operating Activities		 179 104 87 157 190 298 269 151 361 411 584
Net Income / (Loss) Continuing Operations		 63 24 6.84 127 140 101 220 174 233 294 344
Consolidated Net Income / (Loss)		 63 24 6.84 127 140 101 220 174 233 294 344
Depreciation Expense		 62 62 62 59 61 62 58 83 86 83 85
Amortization Expense		 - - - 0.00 7.38 8.57 9.49 9.92 9.23 9.09 10
Non-Cash Adjustments To Reconcile Net Income		 58 48 -78 -35 -15 79 -20 0.76 36 38 90
Changes in Operating Assets and Liabilities, net		 -3.84 -29 96 5.52 -2.80 47 2.35 -117 -3.24 -13 56
Net Cash From Investing Activities		 -31 124 14 -101 93 -199 -181 -74 -160 -306 -221
Net Cash From Continuing Investing Activities		 -31 124 14 -101 93 -199 -181 -74 -160 -306 -221
Purchase of Property, Plant & Equipment		 -27 -30 -85 -77 -45 -34 -35 -37 -23 -29 -34
Purchase of Investments		 -824 -569 -467 -470 -572 -632 -763 -6.65 -286 -480 -653
Sale and/or Maturity of Investments		 818 725 564 446 708 498 614 483 145 191 453
Other Investing Activities, net		 1.93 38 1.32 0.43 3.27 2.85 3.72 2.48 4.75 13 13
Net Cash From Financing Activities		 -218 -237 -26 3.82 -295 -45 -55 -174 -133 -193 -306
Net Cash From Continuing Financing Activities		 -218 -237 -26 3.82 -295 -45 -55 -174 -133 -193 -306
Repurchase of Common Equity		 -69 -16 - - - 0.00 0.00 -105 -45 -85 -165
Payment of Dividends		 -27 -26 -26 -26 -32 -38 -45 -57 -70 -83 -110
Other Financing Activities, net		 -1.45 -6.44 0.54 31 -11 -6.54 -9.61 -12 -18 -25 -30
Cash Interest Paid		 41 0.04 28 28 28 0.51 0.55 1.58 0.71 0.72 0.11
Cash Income Taxes Paid		 21 0.05 22 -1.07 30 24 66 110 72 113 72

Quarterly Cash Flow Statements for New York Times

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 53 -82 17 -18 -5.01 -17 15 52 6.54 -70 47
Net Cash From Operating Activities		 137 53 80 126 152 99 114 208 164 92 194
Net Cash From Continuing Operating Activities		 137 53 80 126 152 99 114 211 160 92 194
Net Income / (Loss) Continuing Operations		 110 40 66 64 124 50 83 82 130 88 93
Consolidated Net Income / (Loss)		 110 40 66 64 124 50 83 82 130 88 93
Depreciation Expense		 22 21 21 21 21 21 21 21 21 21 21
Amortization Expense		 2.05 2.22 2.24 2.31 2.32 2.33 2.34 - - 2.76 2.65
Non-Cash Adjustments To Reconcile Net Income		 22 16 13 8.96 20 19 12 23 29 24 21
Changes in Operating Assets and Liabilities, net		 -19 -26 -21 29 -16 6.50 -4.56 90 -29 -43 56
Net Cash From Investing Activities		 -62 -66 -30 -101 -109 -8.34 -44 -97 -72 -23 -74
Net Cash From Continuing Investing Activities		 -62 -66 -30 -101 -109 -8.34 -44 -97 -72 -23 -74
Purchase of Property, Plant & Equipment		 -6.13 -6.42 -7.63 -7.06 -8.06 -9.24 -10 -7.88 -6.53 -11 -10
Purchase of Investments		 -100 -113 -72 -152 -143 -168 -132 -173 -179 -129 -172
Sale and/or Maturity of Investments		 44 52 49 58 31 162 98 78 114 117 108
Other Investing Activities, net		 - 0.55 0.81 -0.06 11 7.23 0.32 5.48 -0.21 0.56 -0.11
Net Cash From Financing Activities		 -21 -69 -34 -42 -48 -107 -54 -59 -85 -139 -74
Net Cash From Continuing Financing Activities		 -21 -69 -34 -42 -48 -107 -54 -59 -85 -139 -74
Repurchase of Common Equity		 -0.96 -32 -9.55 -18 -25 -59 -24 -27 -55 -56 -35
Payment of Dividends		 -18 -19 -21 -21 -21 -22 -30 -29 -29 -30 -37
Other Financing Activities, net		 -1.47 -18 -2.70 -2.49 -2.02 -26 -1.28 -2.25 -0.66 -52 -1.07

Annual Balance Sheets for New York Times

This table presents New York Times' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,418 2,185 2,100 2,197 2,089 2,308 2,564 2,534 2,715 2,841 2,997
Total Current Assets		 863 796 750 894 717 836 953 656 782 936 1,028
Cash & Equivalents		 106 101 183 242 230 286 320 221 289 199 255
Short-Term Investments		 508 450 309 371 202 309 341 126 162 366 387
Accounts Receivable		 207 197 185 222 213 184 233 218 242 250 291
Prepaid Expenses		 19 16 23 25 29 29 33 55 60 50 60
Other Current Assets		 23 33 50 33 42 27 26 36 28 71 35
Plant, Property, & Equipment, net		 632 597 641 639 627 595 575 554 514 489 462
Total Noncurrent Assets		 923 792 709 664 745 877 2,964 1,324 1,419 1,416 1,507
Long-Term Investments		 314 203 241 214 252 287 413 139 258 346 526
Goodwill		 109 135 144 140 139 172 166 414 416 412 409
Intangible Assets		 - - - - - - 14 317 285 258 229
Noncurrent Deferred & Refundable Income Taxes		 309 301 153 128 115 100 96 96 115 111 73
Other Noncurrent Operating Assets		 191 154 171 182 240 319 2,187 288 262 218 270
Total Liabilities & Shareholders' Equity		 2,418 2,185 2,100 2,197 2,089 2,308 2,564 2,534 2,715 2,841 2,997
Total Liabilities		 1,589 1,341 1,202 1,154 915 980 1,023 934 951 914 956
Total Current Liabilities		 564 399 416 673 438 487 559 571 612 614 667
Accounts Payable		 96 104 125 112 117 123 127 115 117 124 136
Accrued Expenses		 121 131 111 120 124 137 146 136 148 125 137
Current Employee Benefit Liabilities		 98 96 105 105 109 121 166 165 174 178 186
Other Current Liabilities		 - - 75 84 88 105 119 156 173 187 208
Total Noncurrent Liabilities		 1,026 942 787 481 478 493 464 363 340 301 289
Noncurrent Employee Benefit Liabilities		 691 617 454 403 351 365 331 252 239 215 211
Other Noncurrent Operating Liabilities		 92 79 82 78 126 128 133 111 101 86 78
Total Equity & Noncontrolling Interests		 828 844 897 1,043 1,174 1,328 1,541 1,600 1,763 1,927 2,041
Total Preferred & Common Equity		 827 848 897 1,041 1,172 1,326 1,539 1,598 1,763 1,927 2,041
Total Common Equity		 827 848 897 1,041 1,172 1,326 1,539 1,598 1,763 1,927 2,041
Common Stock		 163 167 181 224 226 234 248 273 319 374 430
Retained Earnings		 1,329 1,332 1,310 1,506 1,613 1,673 1,845 1,959 2,118 2,325 2,551
Treasury Stock		 -156 -171 -171 -171 -171 -171 - -276 -321 -406 -573
Accumulated Other Comprehensive Income / (Loss)		 -509 -480 -423 -518 -495 -410 -383 -358 -353 -366 -366

Quarterly Balance Sheets for New York Times

This table presents New York Times' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 2,472 2,479 2,547 2,623 2,673 2,762 2,735 2,805 2,887 2,859 2,985
Total Current Assets		 634 675 658 681 716 795 802 855 938 927 1,023
Cash & Equivalents		 235 246 236 207 223 205 183 198 249 187 233
Short-Term Investments		 139 171 163 172 188 288 339 342 368 408 428
Accounts Receivable		 166 159 164 178 181 189 193 211 204 235 236
Prepaid Expenses		 58 61 57 59 50 45 50 58 53 59 68
Other Current Assets		 35 38 39 65 73 68 37 46 64 39 58
Plant, Property, & Equipment, net		 546 531 524 508 503 495 483 478 471 460 455
Total Noncurrent Assets		 1,292 1,273 1,365 1,434 1,454 1,472 1,451 1,472 1,478 1,472 1,506
Long-Term Investments		 100 94 189 307 313 327 380 411 479 513 555
Goodwill		 415 415 413 415 414 417 415 409 409 408 407
Intangible Assets		 310 303 293 278 272 265 251 243 236 222 215
Noncurrent Deferred & Refundable Income Taxes		 106 116 116 121 128 131 123 128 73 62 50
Other Noncurrent Operating Assets		 361 346 353 313 328 332 281 280 280 268 278
Total Liabilities & Shareholders' Equity		 2,472 2,479 2,547 2,623 2,673 2,762 2,735 2,805 2,887 2,859 2,985
Total Liabilities		 895 872 891 875 868 910 850 869 907 858 937
Total Current Liabilities		 540 532 554 545 543 590 555 578 615 578 648
Accounts Payable		 122 111 120 121 121 137 122 120 131 138 155
Accrued Expenses		 155 125 140 157 123 129 144 134 124 123 133
Current Employee Benefit Liabilities		 100 139 138 89 124 146 96 133 162 101 149
Other Current Liabilities		 164 157 157 178 175 177 194 190 198 216 211
Total Noncurrent Liabilities		 355 340 337 330 325 320 295 291 291 280 289
Noncurrent Employee Benefit Liabilities		 249 246 240 236 233 230 215 212 209 207 211
Other Noncurrent Operating Liabilities		 106 93 97 94 92 90 80 79 83 73 78
Total Equity & Noncontrolling Interests		 1,577 1,607 1,655 1,748 1,805 1,852 1,885 1,936 1,980 2,001 2,048
Total Preferred & Common Equity		 1,575 1,605 1,653 1,748 1,805 1,852 1,885 1,936 1,980 2,001 2,048
Total Common Equity		 1,575 1,605 1,653 1,748 1,805 1,852 1,885 1,936 1,980 2,001 2,048
Common Stock		 273 286 298 317 338 352 365 387 404 396 421
Retained Earnings		 1,963 1,991 2,026 2,137 2,180 2,223 2,345 2,398 2,450 2,601 2,657
Treasury Stock		 -307 - -320 -354 - -382 -466 -489 -517 -629 -665
Accumulated Other Comprehensive Income / (Loss)		 -354 -352 -351 -352 -350 -342 -360 -360 -357 -366 -365

Annual Metrics And Ratios for New York Times

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -0.59% -1.51% 7.09% 4.72% 3.90% -1.58% 16.33% 11.25% 5.10% 6.59% 9.24%
EBITDA Growth		 15.62% -17.59% 6.68% 38.26% -1.90% -33.23% 105.66% -11.30% 30.04% 17.26% 15.76%
EBIT Growth		 48.55% -25.61% 10.59% 61.88% -7.48% -48.24% 195.69% -24.17% 42.86% 24.35% 19.04%
NOPAT Growth		 -13.75% 8.62% -88.02% 1,092.85% 8.56% 3.04% 31.82% -26.67% 42.79% 26.61% 22.27%
Net Income Growth		 94.53% -62.08% -71.31% 1,764.27% 9.81% -27.96% 118.15% -20.94% 33.84% 26.24% 17.07%
EPS Growth		 90.00% -52.63% -83.33% 2,400.00% 10.67% -27.71% 118.33% -20.61% 34.62% 26.43% 18.08%
Operating Cash Flow Growth		 122.48% -41.99% -16.52% 81.19% 20.86% 56.89% -9.68% -44.00% 139.32% 13.84% 42.38%
Free Cash Flow Firm Growth		 -32.27% -31.17% -171.79% 226.69% 57.02% 52.87% -982.08% 181.90% -80.95% 13.06% 52.99%
Invested Capital Growth		 -11.44% 1.73% 22.65% 13.32% 4.27% -8.95% 436.59% -53.48% -5.36% -3.67% -13.97%
Revenue Q/Q Growth		 0.00% -0.32% 2.54% 1.18% 0.39% 31.56% -14.15% 3.28% 0.36% 1.99% 2.75%
EBITDA Q/Q Growth		 11.22% -16.37% -19.12% 26.24% 4.88% -32.85% 39.45% 2.63% 11.46% 3.61% 4.38%
EBIT Q/Q Growth		 22.67% -24.01% -26.43% 37.85% 2.15% -47.26% 56.82% -0.09% 15.99% 4.80% 2.82%
NOPAT Q/Q Growth		 5.46% 8.30% -88.55% 436.76% 13.74% 3.64% 1.35% -0.56% 17.33% 5.80% 2.66%
Net Income Q/Q Growth		 39.66% -37.09% -93.32% 907.99% 8.73% -36.30% 36.78% 0.52% 20.41% 4.81% 1.81%
EPS Q/Q Growth		 35.71% -30.77% -95.00% 837.50% 9.21% -36.17% 39.36% -0.95% 21.74% 4.12% 2.45%
Operating Cash Flow Q/Q Growth		 17.59% -33.70% -47.80% 184.67% 16.97% 8.35% -10.54% 4.23% 24.45% 3.84% 2.18%
Free Cash Flow Firm Q/Q Growth		 -47.43% -47.64% -244.63% 176.43% 4.79% 25.59% -857.39% 387.48% 45.26% 6.08% 0.46%
Invested Capital Q/Q Growth		 -5.85% 25.72% 27.71% 2.57% 5.13% -2.40% 460.61% 3.72% -1.26% -1.58% -1.13%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 60.88% 59.54% 84.83% 45.65% 45.47% 46.22% 49.90% 47.63% 48.52% 49.36% 50.81%
EBITDA Margin		 12.55% 10.50% 10.46% 13.81% 13.04% 8.85% 15.64% 12.47% 15.43% 16.98% 17.99%
Operating Margin		 8.65% 7.24% 10.60% 10.90% 9.69% 9.88% 12.92% 8.75% 11.39% 13.58% 15.28%
EBIT Margin		 8.65% 6.53% 6.75% 10.43% 9.29% 4.88% 12.41% 8.46% 11.50% 13.42% 14.62%
Profit (Net Income) Margin		 3.98% 1.53% 0.41% 7.31% 7.72% 5.65% 10.60% 7.53% 9.59% 11.36% 12.18%
Tax Burden Percent		 64.95% 78.07% 6.15% 72.38% 85.11% 87.36% 75.72% 73.69% 76.92% 76.63% 76.23%
Interest Burden Percent		 70.84% 30.04% 98.98% 96.81% 97.73% 132.53% 112.79% 120.83% 108.45% 110.52% 109.26%
Effective Tax Rate		 35.05% 14.48% 93.47% 27.62% 14.89% 12.64% 24.28% 26.31% 23.08% 23.37% 23.77%
Return on Invested Capital (ROIC)		 25.08% 28.75% 3.07% 31.12% 31.14% 32.90% 14.29% 8.49% 19.61% 26.00% 34.83%
ROIC Less NNEP Spread (ROIC-NNEP)		 31.17% 43.22% 4.02% 33.05% 32.64% 39.68% -103.53% 22.16% 16.22% 22.95% 33.39%
Return on Net Nonoperating Assets (RNNOA)		 -17.00% -25.90% -2.28% -17.98% -18.51% -24.84% 1.04% 2.59% -5.77% -10.08% -17.50%
Return on Equity (ROE)		 8.07% 2.85% 0.79% 13.14% 12.63% 8.06% 15.34% 11.07% 13.84% 15.92% 17.34%
Cash Return on Invested Capital (CROIC)		 37.21% 27.03% -17.28% 18.63% 26.96% 42.26% -122.87% 81.48% 25.11% 29.74% 49.85%
Operating Return on Assets (OROA)		 5.48% 4.41% 5.24% 8.47% 7.85% 3.96% 10.57% 7.66% 10.63% 12.49% 14.15%
Return on Assets (ROA)		 2.52% 1.04% 0.32% 5.93% 6.53% 4.59% 9.03% 6.82% 8.87% 10.58% 11.78%
Return on Common Equity (ROCE)		 8.05% 2.85% 0.79% 13.13% 12.61% 8.05% 15.31% 11.06% 13.83% 15.92% 17.34%
Return on Equity Simple (ROE_SIMPLE)		 7.60% 2.81% 0.76% 12.25% 11.94% 7.61% 14.30% 10.88% 13.20% 15.25% 0.00%
Net Operating Profit after Tax (NOPAT)		 89 96 12 138 149 154 203 149 213 269 329
NOPAT Margin		 5.62% 6.20% 0.69% 7.89% 8.25% 8.63% 9.78% 6.45% 8.76% 10.40% 11.65%
Net Nonoperating Expense Percent (NNEP)		 -6.09% -14.47% -0.95% -1.93% -1.51% -6.79% 117.83% -13.67% 3.39% 3.06% 1.44%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 9.30% 12.05% 13.96% 16.12%
Cost of Revenue to Revenue		 39.12% 40.46% 15.17% 54.35% 54.53% 53.78% 50.10% 52.37% 51.48% 50.64% 49.19%
SG&A Expenses to Revenue		 45.20% 46.83% 48.94% 11.27% 11.41% 12.53% 12.05% 12.53% 12.82% 11.91% 11.61%
R&D to Revenue		 0.00% 0.00% 0.00% 4.82% 5.87% 7.48% 7.75% 8.85% 9.43% 9.60% 9.36%
Operating Expenses to Revenue		 52.23% 52.29% 74.23% 34.75% 35.78% 36.33% 36.98% 38.88% 37.13% 35.78% 35.53%
Earnings before Interest and Taxes (EBIT)		 137 102 112 182 168 87 258 195 279 347 413
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 198 163 174 241 236 158 325 288 374 439 508
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.49 2.42 3.17 3.39 4.36 6.26 5.03 3.28 4.51 4.42 5.51
Price to Tangible Book Value (P/TBV)		 2.87 2.88 3.77 3.92 4.95 7.19 5.69 6.05 7.49 6.77 8.01
Price to Revenue (P/Rev)		 1.30 1.32 1.71 2.02 2.82 4.65 3.73 2.27 3.28 3.29 3.98
Price to Earnings (P/E)		 32.56 70.72 662.05 28.06 36.53 82.92 35.15 30.15 34.22 28.97 32.68
Dividend Yield		 1.26% 1.25% 0.91% 0.75% 0.62% 0.46% 0.59% 1.07% 0.87% 0.96% 0.97%
Earnings Yield		 3.07% 1.41% 0.15% 3.56% 2.74% 1.21% 2.84% 3.32% 2.92% 3.45% 3.06%
Enterprise Value to Invested Capital (EV/IC)		 4.71 4.57 5.70 6.29 9.04 16.64 2.78 4.27 6.87 7.49 11.53
Enterprise Value to Revenue (EV/Rev)		 0.99 0.99 1.42 1.70 2.44 4.16 3.21 2.06 2.99 2.94 3.57
Enterprise Value to EBITDA (EV/EBITDA)		 7.89 9.47 13.55 12.27 18.75 47.03 20.52 16.53 19.35 17.31 19.82
Enterprise Value to EBIT (EV/EBIT)		 11.45 15.22 21.02 16.25 26.33 85.20 25.86 24.37 25.96 21.91 24.39
Enterprise Value to NOPAT (EV/NOPAT)		 17.64 16.04 204.65 21.48 29.65 48.20 32.82 31.98 34.09 28.25 30.62
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.74 14.88 27.23 18.82 23.33 24.91 24.75 31.58 20.09 18.51 17.23
Enterprise Value to Free Cash Flow (EV/FCFF)		 11.89 17.07 0.00 35.88 34.24 37.52 0.00 3.33 26.61 24.70 21.40
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.52 0.29 0.28 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.29 0.29 0.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.55 -0.60 -0.57 -0.54 -0.57 -0.63 -0.01 0.12 -0.36 -0.44 -0.52
Leverage Ratio		 3.20 2.75 2.46 2.21 1.93 1.76 1.70 1.62 1.56 1.51 1.47
Compound Leverage Factor		 2.27 0.83 2.44 2.14 1.89 2.33 1.92 1.96 1.69 1.66 1.61
Debt to Total Capital		 34.23% 22.63% 21.80% 19.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 14.95% 0.00% 0.00% 19.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 19.28% 22.63% 21.80% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.14% -0.33% 0.01% 0.14% 0.16% 0.20% 0.13% 0.13% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 65.63% 77.69% 78.19% 80.29% 99.84% 99.80% 99.87% 99.87% 100.00% 100.00% 100.00%
Debt to EBITDA		 2.18 1.51 1.44 1.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -2.50 -3.10 -2.77 -2.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 1.23 1.51 1.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 4.86 2.56 21.68 1.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -5.59 -5.25 -41.83 -4.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 2.74 2.56 21.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 2.53 2.86 3.45 3.98 5.73 7.18 6.87 5.66 7.42 8.18 9.79
Noncontrolling Interest Sharing Ratio		 0.24% -0.11% -0.20% 0.10% 0.17% 0.18% 0.16% 0.13% 0.06% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.53 2.00 1.80 1.33 1.64 1.72 1.70 1.15 1.28 1.53 1.54
Quick Ratio		 1.46 1.87 1.63 1.24 1.48 1.60 1.60 0.99 1.13 1.33 1.40
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 132 91 -65 82 129 198 -1,745 1,429 272 308 471
Operating Cash Flow to CapEx		 664.10% 345.16% 102.31% 202.77% 417.90% 864.80% 776.91% 407.69% 1,590.80% 1,407.16% 1,719.89%
Free Cash Flow to Firm to Interest Expense		 3.37 2.60 -3.29 4.97 33.87 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 4.59 2.98 4.38 9.48 49.71 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 3.90 2.12 0.10 4.81 37.82 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.63 0.68 0.78 0.81 0.85 0.81 0.85 0.91 0.92 0.93 0.97
Accounts Receivable Turnover		 7.52 7.69 8.71 8.56 8.32 8.98 9.96 10.25 10.55 10.51 10.46
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 2.43 2.53 2.69 2.73 2.86 2.92 3.55 4.09 4.54 5.16 5.94
Accounts Payable Turnover		 6.49 6.28 2.20 8.00 8.66 8.00 8.31 10.00 10.79 10.89 10.72
Days Sales Outstanding (DSO)		 48.52 47.47 41.88 42.62 43.89 40.63 36.64 35.61 34.60 34.72 34.91
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 56.27 58.15 166.09 45.64 42.13 45.61 43.93 36.49 33.84 33.52 34.04
Cash Conversion Cycle (CCC)		 -7.75 -10.69 -124.21 -3.01 1.76 -4.98 -7.29 -0.88 0.77 1.20 0.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 332 338 415 470 490 446 2,394 1,114 1,054 1,015 874
Invested Capital Turnover		 4.46 4.64 4.43 3.94 3.78 3.81 1.46 1.32 2.24 2.50 2.99
Increase / (Decrease) in Invested Capital		 -43 5.77 77 55 20 -44 1,948 -1,280 -60 -39 -142
Enterprise Value (EV)		 1,565 1,546 2,362 2,956 4,431 7,421 6,660 4,759 7,244 7,601 10,073
Market Capitalization		 2,059 2,056 2,844 3,527 5,113 8,301 7,733 5,244 7,953 8,512 11,241
Book Value per Share		 $5.11 $5.26 $5.53 $6.31 $7.06 $7.93 $9.17 $9.66 $10.72 $11.75 $12.57
Tangible Book Value per Share		 $4.43 $4.43 $4.65 $5.46 $6.22 $6.90 $8.09 $5.24 $6.46 $7.67 $8.64
Total Capital		 1,260 1,091 1,148 1,296 1,174 1,328 1,541 1,600 1,763 1,927 2,041
Total Debt		 431 247 250 254 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 243 247 250 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -496 -506 -483 -573 -684 -882 -1,074 -486 -709 -912 -1,168
Capital Expenditures (CapEx)		 27 30 85 77 45 34 35 37 23 29 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -126 -153 -157 -139 -153 -246 -267 -263 -281 -243 -281
Debt-free Net Working Capital (DFNWC)		 487 397 334 474 279 349 394 84 170 323 361
Net Working Capital (NWC)		 299 397 334 221 279 349 394 84 170 323 361
Net Nonoperating Expense (NNE)		 26 73 4.70 10 9.47 53 -17 -25 -20 -25 -15
Net Nonoperating Obligations (NNO)		 -496 -506 -483 -573 -684 -882 853 -486 -709 -912 -1,168
Total Depreciation and Amortization (D&A)		 62 62 62 59 68 71 67 93 95 92 95
Debt-free, Cash-free Net Working Capital to Revenue		 -7.98% -9.82% -9.45% -7.94% -8.45% -13.80% -12.89% -11.39% -11.60% -9.40% -9.94%
Debt-free Net Working Capital to Revenue		 30.86% 25.55% 20.06% 27.19% 15.40% 19.57% 18.97% 3.66% 7.01% 12.48% 12.79%
Net Working Capital to Revenue		 18.93% 25.55% 20.06% 12.65% 15.40% 19.57% 18.97% 3.66% 7.01% 12.48% 12.79%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.38 $0.18 $0.03 $0.76 $0.84 $0.60 $1.31 $1.04 $1.41 $1.79 $2.11
Adjusted Weighted Average Basic Shares Outstanding		 164.39M 161.13M 161.93M 164.85M 166.04M 166.97M 167.93M 166.87M 164.72M 164.43M 163.16M
Adjusted Diluted Earnings per Share		 $0.38 $0.18 $0.03 $0.75 $0.83 $0.60 $1.31 $1.04 $1.40 $1.77 $2.09
Adjusted Weighted Average Diluted Shares Outstanding		 166.42M 162.82M 164.26M 166.94M 167.55M 168.04M 168.53M 167.14M 165.66M 165.80M 164.94M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 160.21M 161.20M 164.82M 165.92M 166.40M 167.44M 167.53M 164.47M 164.10M 163.30M 161.24M
Normalized Net Operating Profit after Tax (NOPAT)		 89 110 124 138 153 154 206 177 224 277 341
Normalized NOPAT Margin		 5.62% 7.10% 7.42% 7.89% 8.43% 8.63% 9.92% 7.69% 9.24% 10.72% 12.08%
Pre Tax Income Margin		 6.13% 1.96% 6.68% 10.10% 9.08% 6.47% 14.00% 10.22% 12.47% 14.83% 15.97%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.50 2.92 5.68 10.98 44.05 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 2.27 2.77 0.58 8.31 39.12 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 2.81 2.05 1.40 6.30 32.16 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 1.58 1.90 -3.70 3.63 27.22 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 42.33% 108.66% 380.34% 20.73% 22.58% 38.12% 20.61% 32.66% 30.00% 28.20% 32.08%
Augmented Payout Ratio		 152.59% 174.48% 380.34% 20.73% 22.58% 38.12% 20.61% 93.07% 49.14% 57.14% 80.15%

Quarterly Metrics And Ratios for New York Times

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 161,238,685.00 161,862,699.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 161,238,685.00 161,862,699.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.55 0.58
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 1.30% 5.93% 5.80% 6.99% 7.46% 7.05% 9.72% 9.47% 10.42% 12.00% 11.17%
EBITDA Growth		 33.41% 35.21% 25.18% 12.16% 9.95% 10.70% 24.20% 23.20% 5.23% 42.03% 9.96%
EBIT Growth		 42.15% 65.36% 38.84% 17.78% 12.25% 14.23% 30.01% 32.34% 7.79% 61.19% 12.24%
NOPAT Growth		 44.72% 78.94% 40.29% 18.84% 14.62% 29.44% 32.43% 36.89% 7.37% 78.42% 11.25%
Net Income Growth		 55.74% 81.07% 40.72% 19.64% 12.23% 22.60% 26.56% 27.29% 4.94% 77.44% 12.63%
EPS Growth		 59.52% 84.62% 42.86% 21.88% 10.45% 25.00% 25.00% 28.21% 6.76% 80.00% 14.00%
Operating Cash Flow Growth		 107.91% 4.63% 16.19% 20.31% 11.12% 86.68% 41.64% 65.42% 8.21% -6.92% 70.95%
Free Cash Flow Firm Growth		 -88.05% 221.29% 132.89% 70.46% -3.80% 64.43% 132.79% 142.76% 71.98% 35.87% 36.93%
Invested Capital Growth		 -5.36% -3.69% -1.44% -3.35% -3.67% -7.46% -8.96% -14.37% -13.97% -8.98% -15.54%
Revenue Q/Q Growth		 13.01% -12.16% 5.23% 2.41% 13.50% -12.48% 7.86% 2.18% 14.48% -11.23% 7.05%
EBITDA Q/Q Growth		 74.82% -54.33% 44.12% -2.52% 71.37% -54.02% 61.70% -3.31% 46.38% -37.94% 25.19%
EBIT Q/Q Growth		 101.89% -63.56% 65.84% -3.46% 92.40% -62.92% 88.74% -1.73% 56.71% -44.54% 31.42%
NOPAT Q/Q Growth		 108.84% -65.50% 70.32% -3.17% 101.43% -61.04% 74.26% 0.09% 57.99% -35.25% 8.65%
Net Income Q/Q Growth		 105.62% -63.34% 62.16% -2.13% 92.89% -59.95% 67.39% -1.56% 59.02% -32.28% 6.25%
EPS Q/Q Growth		 109.38% -64.18% 66.67% -2.50% 89.74% -59.46% 66.67% 0.00% 58.00% -31.65% 5.56%
Operating Cash Flow Q/Q Growth		 30.87% -61.12% 51.15% 56.43% 20.87% -34.68% 14.68% 82.69% -20.93% -43.81% 110.62%
Free Cash Flow Firm Q/Q Growth		 193.65% -53.05% -0.22% 23.92% 65.72% -19.75% 41.26% 29.22% 17.40% -36.60% 42.36%
Invested Capital Q/Q Growth		 -1.26% 0.73% 1.82% -4.56% -1.58% -3.23% 0.17% -10.23% -1.13% 2.38% -7.05%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 52.51% 46.66% 48.36% 48.16% 53.48% 47.38% 50.61% 50.19% 54.23% 49.04% 51.76%
EBITDA Margin		 22.73% 11.82% 16.18% 15.40% 23.26% 12.22% 18.32% 17.34% 22.17% 15.49% 18.12%
Operating Margin		 19.08% 8.13% 12.70% 11.99% 20.18% 9.22% 15.54% 14.95% 20.14% 12.72% 15.48%
EBIT Margin		 19.18% 7.96% 12.54% 11.82% 20.04% 8.49% 14.86% 14.29% 19.56% 12.22% 15.00%
Profit (Net Income) Margin		 16.30% 6.80% 10.48% 10.02% 17.03% 7.79% 12.09% 11.65% 16.18% 12.34% 12.25%
Tax Burden Percent		 78.82% 72.62% 75.26% 75.42% 79.49% 77.46% 74.28% 75.60% 77.46% 89.43% 74.61%
Interest Burden Percent		 107.83% 117.74% 111.09% 112.38% 106.89% 118.47% 109.57% 107.84% 106.81% 112.96% 109.47%
Effective Tax Rate		 21.18% 27.38% 24.74% 24.58% 20.51% 22.54% 25.72% 24.40% 22.54% 10.57% 25.39%
Return on Invested Capital (ROIC)		 33.67% 13.43% 21.89% 21.84% 40.09% 18.36% 30.05% 32.45% 46.66% 35.18% 37.89%
ROIC Less NNEP Spread (ROIC-NNEP)		 32.24% 12.51% 20.96% 20.95% 39.21% 17.84% 29.59% 32.20% 46.21% 34.49% 37.39%
Return on Net Nonoperating Assets (RNNOA)		 -11.46% -4.37% -7.58% -8.41% -17.22% -7.80% -13.26% -16.11% -24.22% -17.83% -20.35%
Return on Equity (ROE)		 22.21% 9.06% 14.31% 13.43% 22.87% 10.56% 16.79% 16.35% 22.44% 17.34% 17.54%
Cash Return on Invested Capital (CROIC)		 25.11% 24.83% 23.96% 27.64% 29.74% 35.09% 38.34% 48.94% 49.85% 48.30% 58.03%
Operating Return on Assets (OROA)		 17.73% 7.68% 12.14% 11.29% 18.65% 8.33% 14.58% 13.91% 18.93% 12.67% 15.43%
Return on Assets (ROA)		 15.07% 6.57% 10.15% 9.57% 15.85% 7.64% 11.87% 11.34% 15.66% 12.80% 12.60%
Return on Common Equity (ROCE)		 22.19% 9.05% 14.30% 13.42% 22.87% 10.56% 16.79% 16.35% 22.44% 17.34% 17.54%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 14.35% 14.95% 15.14% 0.00% 16.07% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 102 35 60 58 117 45 79 79 125 81 88
NOPAT Margin		 15.04% 5.91% 9.56% 9.04% 16.04% 7.14% 11.54% 11.30% 15.60% 11.38% 11.55%
Net Nonoperating Expense Percent (NNEP)		 1.43% 0.92% 0.94% 0.89% 0.88% 0.52% 0.45% 0.25% 0.45% 0.69% 0.50%
Return On Investment Capital (ROIC_SIMPLE)		 5.77% - - - 6.05% 2.41% 4.09% 4.00% 6.13% 4.05% 4.30%
Cost of Revenue to Revenue		 47.49% 53.34% 51.64% 51.84% 46.52% 52.62% 49.39% 49.81% 45.77% 50.96% 48.24%
SG&A Expenses to Revenue		 11.22% 13.27% 12.30% 11.90% 10.46% 12.57% 12.04% 10.94% 11.09% 12.14% 11.25%
R&D to Revenue		 8.62% 10.64% 9.95% 9.53% 8.50% 10.46% 9.32% 9.56% 8.34% 9.86% 9.23%
Operating Expenses to Revenue		 33.43% 38.52% 35.66% 36.18% 33.30% 38.16% 35.07% 35.24% 34.09% 36.32% 36.28%
Earnings before Interest and Taxes (EBIT)		 130 47 78 76 146 54 102 100 157 87 114
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 154 70 101 99 169 78 126 121 178 110 138
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.51 4.04 4.65 4.92 4.42 4.28 4.70 4.70 5.51 6.73 5.51
Price to Tangible Book Value (P/TBV)		 7.49 6.70 7.50 7.79 6.77 6.62 7.09 6.98 8.01 9.82 7.92
Price to Revenue (P/Rev)		 3.28 2.87 3.37 3.60 3.29 3.07 3.38 3.39 3.98 4.64 3.79
Price to Earnings (P/E)		 34.22 28.21 31.15 32.58 28.97 26.64 28.40 27.57 32.68 35.21 28.75
Dividend Yield		 0.87% 1.02% 0.90% 0.86% 0.96% 1.05% 1.02% 1.08% 0.97% 0.86% 1.10%
Earnings Yield		 2.92% 3.54% 3.21% 3.07% 3.45% 3.75% 3.52% 3.63% 3.06% 2.84% 3.48%
Enterprise Value to Invested Capital (EV/IC)		 6.87 6.01 7.09 8.05 7.49 7.30 8.28 9.30 11.53 13.82 12.12
Enterprise Value to Revenue (EV/Rev)		 2.99 2.59 3.08 3.27 2.94 2.73 3.03 2.99 3.57 4.26 3.38
Enterprise Value to EBITDA (EV/EBITDA)		 19.35 16.25 18.57 19.59 17.31 16.06 17.30 16.88 19.82 22.85 18.21
Enterprise Value to EBIT (EV/EBIT)		 25.96 21.43 24.00 25.07 21.91 20.27 21.60 20.46 24.39 27.70 21.97
Enterprise Value to NOPAT (EV/NOPAT)		 34.09 27.99 31.29 32.64 28.25 25.65 27.25 25.65 30.62 33.85 26.95
Enterprise Value to Operating Cash Flow (EV/OCF)		 20.09 17.58 20.50 21.00 18.51 15.70 16.63 14.37 17.23 21.39 15.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 26.61 23.75 29.39 28.61 24.70 19.98 20.58 17.54 21.40 27.26 19.13
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.36 -0.35 -0.36 -0.40 -0.44 -0.44 -0.45 -0.50 -0.52 -0.52 -0.54
Leverage Ratio		 1.56 1.53 1.51 1.51 1.51 1.47 1.46 1.47 1.47 1.44 1.45
Compound Leverage Factor		 1.68 1.80 1.68 1.70 1.61 1.75 1.60 1.59 1.57 1.63 1.59
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.23 7.05 8.05 8.24 7.95 8.03 8.67 8.55 9.51 11.95 9.75
Noncontrolling Interest Sharing Ratio		 0.06% 0.06% 0.06% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.28 1.25 1.32 1.35 1.53 1.44 1.48 1.52 1.54 1.60 1.58
Quick Ratio		 1.13 1.02 1.09 1.16 1.33 1.29 1.30 1.33 1.40 1.44 1.38
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 161 76 76 94 155 125 176 227 267 169 241
Operating Cash Flow to CapEx		 2,227.05% 826.26% 1,051.52% 1,777.45% 1,882.55% 1,072.73% 1,099.44% 2,635.29% 2,512.70% 860.17% 1,921.31%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.92 0.97 0.97 0.96 0.93 0.98 0.98 0.97 0.97 1.04 1.03
Accounts Receivable Turnover		 10.55 14.31 14.66 14.37 10.51 14.20 13.70 13.99 10.46 13.58 13.32
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 4.54 4.67 4.82 4.98 5.16 5.31 5.48 5.69 5.94 6.16 6.38
Accounts Payable Turnover		 10.79 10.38 10.98 10.06 10.89 10.96 11.14 10.15 10.72 10.93 10.52
Days Sales Outstanding (DSO)		 34.60 25.50 24.90 25.41 34.72 25.71 26.63 26.09 34.91 26.88 27.40
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 33.84 35.17 33.25 36.27 33.52 33.31 32.75 35.95 34.04 33.39 34.70
Cash Conversion Cycle (CCC)		 0.77 -9.68 -8.35 -10.86 1.20 -7.61 -6.12 -9.86 0.87 -6.51 -7.30
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,054 1,062 1,081 1,032 1,015 983 984 883 874 894 831
Invested Capital Turnover		 2.24 2.27 2.29 2.42 2.50 2.57 2.60 2.87 2.99 3.09 3.28
Increase / (Decrease) in Invested Capital		 -60 -41 -16 -36 -39 -79 -97 -148 -142 -88 -153
Enterprise Value (EV)		 7,244 6,380 7,669 8,301 7,601 7,168 8,147 8,218 10,073 12,356 10,076
Market Capitalization		 7,953 7,067 8,393 9,121 8,512 8,070 9,098 9,315 11,241 13,463 11,292
Book Value per Share		 $10.72 $10.62 $10.99 $11.28 $11.75 $11.54 $11.87 $12.16 $12.57 $12.41 $12.65
Tangible Book Value per Share		 $6.46 $6.41 $6.81 $7.13 $7.67 $7.46 $7.87 $8.20 $8.64 $8.50 $8.80
Total Capital		 1,763 1,748 1,805 1,852 1,927 1,885 1,936 1,980 2,041 2,001 2,048
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -709 -686 -724 -820 -912 -902 -952 -1,097 -1,168 -1,107 -1,216
Capital Expenditures (CapEx)		 6.13 6.42 7.63 7.06 8.06 9.24 10 7.88 6.53 11 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -281 -243 -238 -288 -243 -275 -263 -295 -281 -245 -285
Debt-free Net Working Capital (DFNWC)		 170 136 173 205 323 247 277 323 361 349 375
Net Working Capital (NWC)		 170 136 173 205 323 247 277 323 361 349 375
Net Nonoperating Expense (NNE)		 -8.54 -5.33 -5.77 -6.27 -7.16 -4.13 -3.80 -2.43 -4.68 -6.89 -5.37
Net Nonoperating Obligations (NNO)		 -709 -686 -724 -820 -912 -902 -952 -1,097 -1,168 -1,107 -1,216
Total Depreciation and Amortization (D&A)		 24 23 23 23 23 24 24 21 21 23 24
Debt-free, Cash-free Net Working Capital to Revenue		 -11.60% -9.86% -9.56% -11.34% -9.40% -10.48% -9.79% -10.71% -9.94% -8.45% -9.58%
Debt-free Net Working Capital to Revenue		 7.01% 5.55% 6.94% 8.10% 12.48% 9.39% 10.30% 11.74% 12.79% 12.04% 12.61%
Net Working Capital to Revenue		 7.01% 5.55% 6.94% 8.10% 12.48% 9.39% 10.30% 11.74% 12.79% 12.04% 12.61%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.66 $0.25 $0.40 $0.39 $0.75 $0.30 $0.51 $0.50 $0.80 $0.54 $0.58
Adjusted Weighted Average Basic Shares Outstanding		 164.72M 164.63M 164.54M 164.42M 164.43M 163.78M 163.33M 163.02M 163.16M 162.04M 162.04M
Adjusted Diluted Earnings per Share		 $0.67 $0.24 $0.40 $0.39 $0.74 $0.30 $0.50 $0.50 $0.79 $0.54 $0.57
Adjusted Weighted Average Diluted Shares Outstanding		 165.66M 165.63M 165.51M 165.85M 165.80M 164.91M 164.35M 164.40M 164.94M 163.70M 163.04M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 164.10M 164.31M 164.23M 163.95M 163.30M 163.05M 162.82M 162.35M 161.24M 161.86M 161.28M
Normalized Net Operating Profit after Tax (NOPAT)		 102 36 61 61 119 49 82 81 128 85 92
Normalized NOPAT Margin		 15.04% 6.03% 9.80% 9.58% 16.39% 7.68% 11.92% 11.56% 15.89% 11.91% 12.00%
Pre Tax Income Margin		 20.68% 9.37% 13.93% 13.28% 21.42% 10.06% 16.28% 15.41% 20.89% 13.80% 16.42%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 30.00% 29.25% 28.41% 28.52% 28.20% 28.49% 29.50% 30.32% 32.08% 31.04% 32.14%
Augmented Payout Ratio		 49.14% 47.70% 44.34% 50.39% 57.14% 65.30% 68.70% 70.15% 80.15% 73.60% 76.58%

Financials Breakdown Chart

Key Financial Trends

New York Times Co. (NYSE: NYT) has shown a solid long-term improvement in profitability and cash generation, but the most recent quarter reflects some moderation from the strong pace seen in late 2025. Revenue and earnings are still healthy, and the balance sheet remains conservatively positioned with a large cash/investment base relative to liabilities.

  • Q1 2026 operating revenue rose to $712.2 million, up from $635.9 million in Q1 2025, showing continued top-line growth.
  • Gross profit increased to $349.3 million in Q1 2026 from $301.3 million a year earlier, reflecting stronger monetization and/or a better revenue mix.
  • Operating income improved to $90.6 million in Q1 2026, versus $58.6 million in Q1 2025.
  • Q1 2026 net income rose to $87.9 million, up from $49.6 million in Q1 2025, a meaningful year-over-year gain.
  • Operating cash flow remained strong at $92.2 million in Q1 2026, indicating the business continues to convert earnings into cash.
  • The company held $186.7 million in cash and equivalents plus $407.8 million in short-term investments at the end of Q1 2026, providing ample liquidity.
  • Total equity increased to $2.00 billion in Q1 2026, up from $1.94 billion in Q2 2025 and $1.88 billion in Q1 2025, supporting balance-sheet strength.
  • Over the last several years, NYT’s earnings have trended higher overall, with quarterly net income improving from the low-$20 million range in early 2023 to the $80 million-$120 million range more recently.
  • Q1 2026 revenue was lower than Q4 2025’s $802.3 million, which is not unusual seasonally but does show a pullback from the strongest quarter.
  • Quarterly EPS in Q1 2026 was $0.54, below Q4 2025’s $0.80, though still well above the prior-year Q1 figure of $0.30.
  • Capital spending remains moderate, with Q1 2026 purchases of property, plant and equipment at only $10.7 million.
  • Cash and equivalents declined to $186.7 million in Q1 2026 from $249.3 million in Q3 2025, reflecting the use of cash in the quarter.
  • Net change in cash and equivalents was negative $69.6 million in Q1 2026, driven by investing outflows and shareholder returns.
  • The company continues to return cash through share repurchases and dividends, which is shareholder-friendly but also reduces cash balances.
  • Current liabilities at $577.9 million are sizable relative to current assets of $927.2 million, so liquidity remains important to watch even though the overall balance sheet looks manageable.

Bottom line: NYT appears financially healthy, with improving profits, consistent operating cash flow, and a strong liquidity position. The main watch items are the quarter-to-quarter volatility in cash, the continuing share buybacks/dividends, and whether revenue growth can sustain the stronger pace seen over the past year.

08/10/26 12:37 PM ETAI Generated. May Contain Errors.

New York Times Financials - Frequently Asked Questions

According to the most recent income statement we have on file, New York Times' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

New York Times' net income appears to be on an upward trend, with a most recent value of $343.98 million in 2025, rising from $62.84 million in 2015. The previous period was $293.83 million in 2024. Check out New York Times' forecast to explore projected trends and price targets.

New York Times' total operating income in 2025 was $431.56 million, based on the following breakdown:
  • Total Gross Profit: $1.44 billion
  • Total Operating Expenses: $1.00 billion

Over the last 10 years, New York Times' total revenue changed from $1.58 billion in 2015 to $2.82 billion in 2025, a change of 78.9%.

New York Times' total liabilities were at $955.73 million at the end of 2025, a 4.5% increase from 2024, and a 39.9% decrease since 2015.

In the past 10 years, New York Times' cash and equivalents has ranged from $100.69 million in 2016 to $319.97 million in 2021, and is currently $255.45 million as of their latest financial filing in 2025.

Over the last 10 years, New York Times' book value per share changed from 5.11 in 2015 to 12.57 in 2025, a change of 146.2%.


Related Companies

Financial statements for NYSE:NYT last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for P...
The Tomorrow Investor | Sponsoredtc pixel
SpaceX is NOT the #1 IPO of 2026
A lesser known AI company is growing faster than both SpaceX and OpenAI. Its coding business reportedly grew f...
The Oxford Club | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
If your money lives inside one bank, pay close attention. On December 1st, 2025, a Congressional committee pub...
Decentralized Masters | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
This Junior Silver Explorer Is Closing In on Its Biggest Catalyst
A past-producing Nevada silver project holds a historical 36 million ounce silver-equivalent resource, plus mo...
Wall Street Logic | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel